Pathologies affecting the bladder, such as overactive bladder, interstitial cystitis/bladder pain syndrome and ketamine-induced cystitis have a dramatic effect on quality of life. Unfortunately, the pathological mechanisms are poorly understood and therefore treatment is mostly empirical, often ineffective or with intolerable side effects. Intravesical drug delivery is a therapeutic strategy that provides direct delivery of drugs into the bladder, minimizing systemic side effects associated with oral therapies. However, there is limited knowledge regarding drug distribution across the different bladder layers when an effect beyond the superficial layer is desired. In a proof of concept study, an ex vivo porcine whole bladder model was used to investigate the bladder wall distribution of lidocaine after intravesical instillation with clinically relevant solutions. It was demonstrated that concentrations within all layers of the bladder are dependent on the pH and concentration of the solution administered. Alkalinised lidocaine resulted in higher concentrations within the bladder and was less affected by urine dilution but was also associated with severe urothelial changes. In a subsequent study, the aim was to estimate the concentrations of ketamine accumulated in the urine following recreational use and investigate if urinary ketamine penetrates the bladder wall to achieve harmful concentrations, which ultimately lead to the development of ketamine-induced cystitis. Higher concentration and longer exposure to ketamine were associated with urothelial damage, supporting the hypothesis that urinary ketamine has a direct toxic effect. It has also been proposed that the pathophysiological mechanism involves microvascular changes induced by ketamine. To investigate this further, a viable murine bladder tissue model was developed to study microvascular blood flow regulation, with a particular focus on the role of pericyte cells. Using this model, it was observed that ketamine evoked pericyte-mediated constriction of the suburothelial capillaries of the bladder, which may translate in vivo into reduction of blood flow to the tissue and eventually lead to bladder dysfunction. Overall, this thesis highlights that changes to the barrier function and microvascular blood flow can have an important role in bladder pathophysiology.